Atrial natriuretic peptide decreases circulatory capacitance in areflexic rats.
- 1 September 1986
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 59 (3) , 291-296
- https://doi.org/10.1161/01.res.59.3.291
Abstract
The short-term hemodynamic response to atrial natriuretic peptide appears to be partly mediated by decreased venous return, which could result from increased circulatory capacitance or decreased blood volume. To determine if rat atrial natriuretic peptide 99-126 (0.5 microgram/kg/min IV for 30-70 minutes) dilated capacitance vessels or decreased blood volume, mean circulatory filling pressure (measured during brief circulatory arrest by inflating an intraatrial balloon) and blood volume (51Cr-erythrocytes) were measured in anesthetized rats. Mean circulatory filling pressure, central venous pressure, and blood volume decreased by 0.4 mm Hg, 0.5 mm Hg, and 3.4 ml/kg, respectively. To determine the total circulatory pressure-volume relationship without influence from autonomic reflexes, mean circulatory filling pressure and blood volume were measured in spinal-cord-transected rats before and immediately after infusing or withdrawing 5 ml blood. Atrial natriuretic peptide decreased mean circulatory filling pressure, central venous pressure, and blood volume by 0.9 mm Hg, 1.7 mm Hg, and 8.0 ml/kg, respectively, and displaced the pressure-volume relationship toward the pressure axis by decreasing extrapolated unstressed volume. Similar results were obtained in spinal-cord-transected rats that had initial vascular tone restored to a greater level by norepinephrine infusion. In anephric rats, atrial natriuretic peptide decreased central venous pressure by 0.3 mm Hg and blood volume by 1.6 ml/kg. The results indicate that short-term infusion of atrial natriuretic peptide reduced circulatory capacitance in rats and suggest that this reduction resulted from diminished blood volume due to urinary fluid loss followed by passive vascular recoil and active venoconstriction.(ABSTRACT TRUNCATED AT 250 WORDS)This publication has 18 references indexed in Scilit:
- Atriopeptin III does not Alter Cardiac Performance in RatsJournal Of Hypertension, 1986
- Coronary Vasoconstrictor Effects of Atriopeptin IIScience, 1985
- Ser-Leu-Arg-Arg-Atriopeptin III: The Major Circulating Form of Atrial PeptideScience, 1985
- Atriopeptins as cardiac hormones.Hypertension, 1985
- Atrial natriuretic factor: Structure and functional propertiesKidney International, 1985
- Hemodynamic effects of α-human atrial natriuretic polypeptide (α-HANP) in ratsEuropean Journal of Pharmacology, 1985
- Effects of a synthetic human atrial natriuretic polypeptide on regional blood flow in ratsEuropean Journal of Pharmacology, 1985
- Effects of auriculin (atrial natriuretic factor) on blood pressure, renal function, and the renin-aldosterone system in dogsThe American Journal of Medicine, 1984
- Cardiovascular effects of atrial extracts in anesthetized ratsCanadian Journal of Physiology and Pharmacology, 1984
- A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in ratsLife Sciences, 1981